Alpha-Lipoic Acid Inhibits Endoplasmic Reticulum Stress-induced Cell Death Through PI3K/Akt Signaling Pathway in FRTL5 Thyroid Cells

Abstract

Alpha-lipoic acid (ALA) has been shown to modulate cell death via PI3K/Akt signal pathway in various cells. In the present study, the effects of ALA on cell death and PI3K/Akt signal pathway linked to cell death-related proteins during endoplasmic reticulum (ER) stress in FRTL5 thyroid cells were evaluated. In FRTL5 thyroid cells, cell viability increased by ALA pretreatment in tunicamycin (TN)-treated cells. When TN was treated, CCAAT/enhancer-binding protein-homologous protein (CHOP) and Bax protein levels were elevated while Bcl-2 protein levels were reduced. ALA diminished CHOP and Bax protein levels, and augmented Bcl-2 protein levels in TN-treated cells. After exposure to TN, phospho-Akt protein levels were repressed whereas total Akt protein levels were not changed. ALA increased phospho-Akt protein levels but not total Akt protein levels in both non-TN-treated and TN-treated cells. After LY294002 administration in non-TN-treated cells, cell viability was reduced, and CHOP and Bax protein levels were elevated, and Bcl-2 protein levels were reduced. The CHOP, Bcl-2 and Bax protein levels were not different after LY294002 administration in TN-treated cells. LY294002 and wortmannin decreased cell viability, and increased CHOP and Bax protein levels, and decreased Bcl-2 protein levels in ALA-pretreated and TN-treated cells. In conclusion, these results suggest that ER stress may induce cell death by modulating PI3K/Akt signal pathway linked to cell death-related proteins in FRTL5 thyroid cells. Moreover, these findings imply that ALA may ameliorate ER stress-induced cell death by activating PI3K/Akt signal pathway and attenuating changes of cell death-related proteins in FRTL5 thyroid cells.

Key words

alpha-lipoic acid - cell death - Akt - thyroid - endoplasmic reticulum

References

• 1 Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress.  Cell Death Differ. 2004;  11 381-389
• 2 Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress.  Trends Cell Biol. 2004;  14 20-28
• 3 Kaufman RJ. Orchestrating the unfolded protein response in health and disease.  J Clin Invest. 2002;  110 1389-1398
• 4 Zinszner H, Kuroda M, Wang XZ, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum.  Genes Dev. 1998;  12 982-995
• 5 Mccullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating bcl2 and perturbing the cellular redox state.  Mol Cell Biol. 2001;  21 1249-1259
• 6 Alnemri ES. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases.  J Cell Biochem. 1997;  64 33-42
• 7 Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor G, Thompson CB, Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.  Science. 2001;  292 727-730
• 8 Chan Yu V SL. Proteins of the Bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities.  Clin Exp Pharmacol Physiol. 2004;  31 119-128
• 9 Hockenbery DM, Oltvai ZV, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis.  Cell. 1993;  75 241-251
• 10 Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream.  Cell. 2007;  129 1261-1274
• 11 Hosoi T, Hyoda K, Okuma Y, Nomura Y, Ozawa K. Inhibitory effect of 4-(2-aminoethyl)-benzenesulfonyl fluoride, a serine protease inhibitor, on PI3K inhibitor-induced CHOP expression.  Eur J Pharmacol. 2007;  554 8-11
• 12 Hyoda K, Hosoi T, Horie N, Okuma Y, Ozawa K, Nomura Y. PI3K-Akt inactivation induced CHOP expression in endoplasmic reticulum-stressed cells.  Biochem Biophys Res Commun. 2006;  340 286-290
• 13 Paker L, Witt EH, Tritschler JH. Alpha lipoic acid as a biological antioxidant.  Free Radic Biol Med. 1995;  19 227-250
• 14 Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.  Diabet Med. 2004;  21 114-121
• 15 Cameron NE, Coteer MA, Horrobin DH, Tritschler HJ. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids.  Diabetologia. 1998;  41 390-399
• 16 Marsh SA, Laursen PB, Pat BK, Gobe GC, Coombes JS. Bcl-2 in endothelial cells is increased by vitamin E and alpha-lipoic acid supplementation but not exercise training.  J Mol Cell Cardiol. 2005;  38 445-451
• 17 Shi DY, Liu HL, Stern JS, Yu PZ, Liu SL. Alpha-lipoic acid induces apoptosis in hepatoma cells via the PTEN/Akt pathway.  FEBS Lett. 2008;  582 1667-1671
• 18 Dozio E, Ruscica M, Passafaro L, Dogliotti G, Steffani L, Pagani A, Demartini G, Esposti D, Fraschini F, Magni P. The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells.  Eur J Pharmacol. 2010;  641 29-34
• 19 Moungjaroen J, Nimmannit U, Callery PS, Wang L, Azad N, Lipipun V, Chanvorachote P, Rojanasakul Y. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation.  J Pharmacol Exp Ther. 2006;  319 1062-1069
• 20 Bitar MS, Ayed AK, Abdel-Halim SM, Isenovic ER, Al-Mulla F. Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with α-lipoic acid through phosphatidylinositol 3-kinase/Akt-dependent mechanism.  Life Sci. 2010;  86 844-853
• 21 Artwohl M, Muth K, Kosulin K, de Martin R, Hölzenbein T, Rainer G, Freudenthaler A, Huttary N, Schmetterer L, Waldhäusl WK, Baumgartner-Parzer SM. R-(+)-α-lipoic acid inhibits endothelial cell apoptosis and proliferation: involvement of Akt and retinoblastoma protein/E2F-1.  Am J Physiol Endocrinol Metab. 2007;  293 E681-E689
• 22 Diesel B, Kulhanek-Heinze S, Holtje M, Brandt B, Holtje HD, Vollmar AM, Kiemer AK. Alpha-lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis.  Biochemistry. 2007;  46 2146-2155
• 23 Bitar MS, Wahid S, Pilcher CW, Al-Saleh E, Al-Mulla F. Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats.  Horm Metab Res. 2004;  36 542-549
• 24 Simbula G, Columbano A, Ledda-Columbano GM, Sanna L, Deidda M, Diana A, Pibiri M. Increased reactive oxygen species generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells.  Apoptosis. 2007;  12 113-123
• 25 Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress.  Curr Med Chem. 2004;  11 1135-1146
• 26 Healy SJM, Gorman AM, Mousavi-Shafaei P, Gupta S, Samali A. Targeting the endoplasmic reticulum-stress response as an anticancer strategy.  Eur J Pharmacol. 2009;  625 234-246
• 27 Kim PS, Ding M, Menon S, Jung CG, Cheng JM, Miyamoto T, Li B, Furudate S, Agui T. A missense mutation G2320R in the thyroglobulin gene causes nongoitrous congenital primary hypothyroidism in the WIC-rdw rat.  Mol Endocrinol. 2000;  14 1944-1953
• 28 Ullman E, Fan Y, Stawowczyk M, Chen H-M, Yue Z, Zong W-X. Autophagy promotes necrosis in apoptosis-deficient cells in response to ER stress.  Cell Death and Differ. 2008;  15 422-425
• 29 Müller C, Dünschede F, Koch E, Vollmar AM, Kiemer AK. α-Lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway.  Am J Physiol Gastrointest Liver Physiol. 2003;  285 G769-G778
• 30 Ki SH, Kim SG. Phase II enzyme induction by α-lipoic acid through phosphatidylinositol 3-kinase-dependent C/EBPs activation.  Xenobiotica. 2008;  38 587-604
• 31 Pessler-Cohen D, Pekala PH, Kovsan J, Bloch-Damti A, Rudich A, Bashan N. GLUT4 repression in response to oxidative stress is associated with reciprocal alterations in C/EBP alpha and delta isoforms in 3T3-L1 adipocytes.  Arch Physiol Biochem. 2006;  112 3-12
• 32 Guyton KZ, Xu Q, Holbrook NJ. Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element.  Biochem J. 1996;  314 547-554
• 33 Saito J, Kohn AD, Roth RA, Noguchi Y, Tatsumo I, Hirai A, Suzuki K, Kohn LD, Saji M, Ringel MD. Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling.  Thyroid. 2001;  11 339-351
• 34 Srinivasan S, Ohsugi M, Liu Z, Fatrai S, Bernal-Mizrachi E, Permutt MA. Endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol 3-kinase/Akt and increased glycogen synthase kinase-3beta in mouse insulinoma cells.  Diabetes. 2005;  54 968-975
• 35 Luo HR, Hattori H, Hossain MA, Hester L, Huang Y, Lee-Kwon W, Donowitz M, Nagata E, Snyder SH. Akt as a mediator of cell death.  Proc Natl Acad Sci USA. 2003;  100 11712-11717
• 36 Bailly-Maitre B, Fondevila C, Kaldas F, Droin N, Luciano F, Ricci J-E, Croxton R, Krajewska M, Zapata JM, Kupiec-Weglinski JW, Farmer D, Reed JC. Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury.  Proc Natl Acad Sci USA. 2006;  103 2809-2814
• 37 Duenschede F, Erbes K, Riegler N, Ewald P, Kircher A, Westermann S, Schad A, Miesmer I, Albrecht-Schöck S, Gockel I, Kiemer AK, Junginger T. Protective effects of ischemic preconditioning and application of lipoic acid prior to 90 min of hepatic ischemia in a rat model.  World J Gastroenterol. 2007;  13 3692-3698
• 38 Viglietto G, Amodio N, Malanga D, Scrima M, De Marco C. Contribution of PKB/AKT signaling to thyroid cancer.  Front Biosci. 2011;  16 1461-1487
• 39 Shinohara M, Chung YJ, Saji M, Ringel MD. AKT in thyroid tumorigenesis and progression.  Endocrinology. 2007;  148 942-947
• 40 Wang XZ, Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase.  Science. 1996;  272 1347-1349
• 41 Pomérance M, Carapau D, Chantoux F, Mockey M, Corrèze C, Francon J, Blondeau J-P. CCAAT/enhancer-binding protein-homologous protein expression and transcriptional activity are regulated by 3′,5′-cyclic adenosine monophosphate in thyroid cells.  Mol Endocrinol. 2003;  17 2283-2294
• 42 Zou CG, Cao XZ, Zhao YS, Gao SY, Li SD, Liu XY, Zhang Y, Zhang KQ. The molecular mechanism of endoplasmic reticulum stress-induced apoptosis in PC-12 neuronal cells: the protective effect of insulin-like growth factor I.  Endocrinology. 2009;  150 277-285
• 43 Lee SJ, Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ. Effects of all-trans retinoic acid on sodium/iodide symporter and CCAAT/enhancer-binding protein-homologous protein under condition of endoplasmic reticulum stress in FRTL5 thyroid cells.  Horm Metab Res. 2011;  43 331-336
• 44 Kim HJ, Kim JY, Lee SJ, Kim HJ, Oh CJ, Choi YK, Lee HJ, Do JY, Kim SY, Kwon TK, Choi HS, Lee MO, Park IS, Park KG, Lee KU, Lee IK. α-Lipoic acid prevents neointimal hyperplasia via induction of p38 mitogen-activated protein kinase/Nur77-mediated apoptosis of vascular smooth muscle cells and accelerates postinjury reendothelialization.  Arterioscler Thromb Vasc Biol. 2010;  30 2164-2172
• 45 Lee SJ, Kang JG, Ryu OH, Kim CS, Ihm SH, Choi MG, Yoo HJ, Kim DS, Kim TW. Effects of α-lipoic acid on TGFβ1-p38 MAPK-fibronectin pathway in diabetic nephropathy.  Metabolism. 2009;  58 616-623

Correspondence